C.E.Management Integrated LaboratoryLtd Balance Sheet Health
Financial Health criteria checks 5/6
C.E.Management Integrated LaboratoryLtd has a total shareholder equity of ¥4.7B and total debt of ¥603.0M, which brings its debt-to-equity ratio to 12.7%. Its total assets and total liabilities are ¥6.9B and ¥2.2B respectively. C.E.Management Integrated LaboratoryLtd's EBIT is ¥451.0M making its interest coverage ratio -22.6. It has cash and short-term investments of ¥2.6B.
Key information
12.7%
Debt to equity ratio
JP¥603.00m
Debt
| Interest coverage ratio | -22.6x |
| Cash | JP¥2.59b |
| Equity | JP¥4.73b |
| Total liabilities | JP¥2.20b |
| Total assets | JP¥6.93b |
Recent financial health updates
No updates
Recent updates
C.E.Management Integrated LaboratoryLtd's (TSE:6171) Dividend Will Be ¥6.00
Oct 14
C.E.Management Integrated LaboratoryLtd (TSE:6171) Is Due To Pay A Dividend Of ¥6.00
Sep 29C.E.Management Integrated LaboratoryLtd (TSE:6171) Will Pay A Dividend Of ¥6.00
Aug 27We Think You Can Look Beyond C.E.Management Integrated LaboratoryLtd's (TSE:6171) Lackluster Earnings
Mar 30Financial Position Analysis
Short Term Liabilities: 6171's short term assets (¥4.0B) exceed its short term liabilities (¥1.3B).
Long Term Liabilities: 6171's short term assets (¥4.0B) exceed its long term liabilities (¥922.0M).
Debt to Equity History and Analysis
Debt Level: 6171 has more cash than its total debt.
Reducing Debt: 6171's debt to equity ratio has increased from 0% to 12.7% over the past 5 years.
Debt Coverage: 6171's debt is well covered by operating cash flow (117.9%).
Interest Coverage: 6171 earns more interest than it pays, so coverage of interest payments is not a concern.